Vertex and Arbor Biotechnologies partner to develop novel ex-vivo engineered cell therapies
Vertex to use Arbor’s CRISPR gene-editing technology to enhance efforts in developing novel cell therapies for the treatment of…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
CRISPR gene-editing technology
Merck licenses CRISPR gene-editing technology to Evotec
The licence is to accelerate research, enable testing and development of new drugs